Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. The Company operates its businesses through three segments. The Non-clinical Drug Research Service segment mainly provides non-clinical drug safety evaluation services, pharmacodynamic research services, and pharmacokinetic research services. The Clinical Services and Others segment mainly provides pre-market clinical services and pharmacovigilance services for drugs. The Experimental Model Supply segment is responsible for the production and sales of experimental models and their ancillary products. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)1.98bn
- Net income in CNY387.42m
- Incorporated1998
- Employees2.65k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869582
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Thera Solutions Ltd | 788.13m | -484.68m | 10.95bn | 1.17k | -- | 17.82 | -- | 13.90 | -1.17 | -1.17 | 1.90 | 1.48 | 0.3423 | 0.9395 | 7.29 | -- | -21.05 | -16.38 | -38.36 | -22.22 | 70.34 | 77.05 | -61.50 | -62.11 | 0.6396 | -34.39 | 0.533 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| CARsgen Therapeutics Holdings Ltd | 39.39m | -797.45m | 11.20bn | 468.00 | -- | 10.53 | -- | 284.38 | -1.58 | -1.58 | 0.078 | 2.02 | 0.0201 | 6.49 | 1.77 | 92,168.00 | -40.61 | -76.51 | -45.87 | -89.25 | 37.41 | -- | -2,024.43 | -12,640.86 | 6.00 | -16.33 | 0.1361 | -- | -- | -- | -6.73 | -- | -28.32 | -- |
| Keymed Biosciences Inc | 427.76m | -514.80m | 12.54bn | 1.26k | -- | 4.73 | -- | 29.31 | -2.15 | -2.15 | 1.79 | 9.71 | 0.1119 | 0.1454 | 9.52 | 372,343.10 | -13.46 | -40.63 | -15.64 | -44.60 | 97.15 | -- | -120.27 | -593.20 | 3.15 | -- | 0.2333 | -- | 20.91 | -- | -43.38 | -- | 28.05 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 177.01m | -1.13bn | 12.79bn | 1.42k | -- | 10.01 | -- | 72.24 | -2.83 | -2.83 | 0.443 | 3.20 | 0.0401 | 0.2404 | 5.57 | 125,010.50 | -25.65 | -29.90 | -37.45 | -36.18 | 74.48 | 85.56 | -639.95 | -1,188.68 | 0.8189 | -19.29 | 0.653 | -- | 56.28 | 46.68 | 0.9031 | -- | 12.25 | -- |
| Joinn Laboratories China Co Ltd | 1.98bn | 387.42m | 18.67bn | 2.65k | 48.40 | 2.40 | -- | 9.43 | 0.5376 | 0.5376 | 2.60 | 10.82 | 0.2068 | 0.8932 | 6.88 | 746,931.30 | 4.01 | 6.60 | 4.64 | 7.92 | 27.33 | 41.87 | 19.40 | 25.98 | 3.22 | -- | 0.0065 | 23.59 | -15.07 | 25.85 | -81.34 | -16.89 | 16.27 | -19.46 |
| Onesource Specialty Pharma Ltd | 805.92m | -34.72m | 18.92bn | 525.00 | -- | 3.85 | 169.33 | 23.48 | -3.94 | -4.00 | 85.26 | 513.87 | -- | -- | -- | -- | -- | -- | -- | -- | 74.34 | -- | -4.31 | -- | 0.8335 | 1.30 | 0.1381 | -- | 740.43 | -- | 95.27 | -- | -- | -- |
| Syngene International Ltd | 3.04bn | 414.45m | 21.01bn | 6.53k | 50.85 | 5.32 | 27.28 | 6.91 | 12.31 | 12.31 | 90.44 | 117.75 | 0.5626 | 4.78 | 7.52 | 5,575,387.00 | 7.66 | 8.14 | 9.54 | 10.44 | 74.12 | 71.29 | 13.62 | 15.03 | 1.53 | 11.11 | 0.1089 | -- | 4.41 | 12.60 | -2.71 | 3.78 | 3.67 | -- |
| InventisBio Co Ltd | 168.37m | -214.53m | 21.20bn | 185.00 | -- | 11.97 | -- | 125.89 | -0.3789 | -0.3789 | 0.2941 | 3.06 | 0.0853 | -- | 0.9419 | 910,126.10 | -10.86 | -32.89 | -11.49 | -35.22 | 99.32 | -- | -127.41 | -682.73 | -- | -- | 0.0128 | -- | -9.02 | 25.00 | 15.41 | -- | -3.97 | -- |
| Ascentage Pharma Group International | 979.81m | -405.08m | 24.33bn | 567.00 | -- | 83.26 | -- | 24.84 | -1.38 | -1.38 | 3.55 | 0.917 | 0.3832 | 2.56 | 8.56 | 1,892,280.00 | -15.85 | -30.84 | -27.07 | -41.94 | 97.03 | 94.02 | -41.37 | -252.93 | 1.26 | -18.57 | 0.8589 | -- | 341.77 | 132.25 | 56.20 | -- | -21.49 | -- |
Data as of Jul 11 2025. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
10.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harvest Fund Management Co., Ltd.as of 28 Mar 2024 | 16.32m | 2.59% |
| E Fund Management Co., Ltd.as of 31 Dec 2024 | 12.99m | 2.06% |
| Hwabao WP Fund Management Co., Ltd.as of 31 Mar 2025 | 12.39m | 1.97% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2024 | 8.31m | 1.32% |
| Tian Hong Asset Management Co., Ltd.as of 31 Dec 2024 | 5.17m | 0.82% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2024 | 4.52m | 0.72% |
| GF Fund Management Co., Ltd.as of 31 Dec 2024 | 2.53m | 0.40% |
| Changsheng Fund Management Co., Ltd.as of 31 Dec 2024 | 2.20m | 0.35% |
| Orient Securities Asset Management Co. Ltd.as of 31 Dec 2024 | 1.93m | 0.31% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2024 | 1.88m | 0.30% |
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
